To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide: it's all about choosing the right patient!

被引：0
|
作者：
Satsangi, Sandeep [1 ]
机构：
[1] BGS Gleneagles Global Hosp, 67 Uttarahalli Rd, Bangalore 560060, Karnataka, India
来源：
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2018年 / 30卷 / 06期
关键词：
D O I：
10.1097/MEG.0000000000001104
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：689 / 690
页数：2
相关论文
共 50 条
  • [21] Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
    Hill, Andrew
    Hughes, Sophie L.
    Gotham, Dzintars
    Pozniak, Anton L.
    [J]. JOURNAL OF VIRUS ERADICATION, 2018, 4 (02) : 72 - 79
  • [22] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patient with chronic hepatitis B
    Nam, Heechul
    Han, Ji Won
    Lee, Soon Kyu
    Yang, Hyun
    Lee, Hae Lim
    Sung, Pil Soo
    Song, Myeong Jun
    Kwon, Jung Hyun
    Jang, Jeong Won
    Chang, U-Im
    Kim, Chang Wook
    Nam, Soon Woo
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Yang, Jin Mo
    Kim, Hee Yeon
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (08) : 1673 - 1683
  • [23] Comparison of body weight and lipid profiles following tenofovir disoproxil fumarate or entecavir switching to tenofovir alafenamide-an interim analysis
    Cheng, Pin-Nan
    Liu, Chun-Jen
    Chen, Jyh-Jou
    Feng, I-Cher
    Kuo, Hsing-Tao
    Lee, Pei-Lun
    Yu, Ming-Lung
    Chiu, Yencheng
    Hung-Chih, Chiu
    Chien, Shih-Chieh
    Chen, Pei-Jer
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S863 - S864
  • [24] THE EFFECTS OF ENTECAVIR, TENOFOVIR DISOPROXIL FUMARATE, AND TENOFOVIR ALAFENAMIDE ON THE PROGNOSIS OF TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B INFECTIONS
    Chon, Hye Yeon
    Chun, Ho Soo
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Sinn, Dong Hyun
    Lee, Jeong-Hoon
    Kim, Seung Up
    [J]. HEPATOLOGY, 2020, 72 : 498A - 498A
  • [25] Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back
    Milinkovic, Ana
    Berger, Florian
    Arenas-Pinto, Alejandro
    Mauss, Stefan
    [J]. AIDS, 2019, 33 (15) : 2387 - 2391
  • [26] COMPARATIVE SAFETY OF TENOFOVIR DISOPROXIL FUMARATE AND TENOFOVIR ALAFENAMIDE IN CHRONIC HEPATITIS B PATIENTS
    Yu, N. Y.
    Chang, K. C.
    [J]. VALUE IN HEALTH, 2020, 23 : S532 - S532
  • [27] Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis
    Ma, Xuefeng
    Liu, Shousheng
    Wang, Mengke
    Wang, Yifen
    Du, Shuixian
    Xin, Yongning
    Xuan, Shiying
    [J]. JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (03) : 335 - 344
  • [28] Tenofovir alafenamide as compared to tenofovir disoproxil fumarate in the management of chronic hepatitis B with recent trends in patient demographics
    Hsu, Yao-Chun
    Wei, Mike T.
    Nguyen, Mindie H.
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (11) : 999 - 1008
  • [29] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide: perhaps not as simple as we thought
    Mak, Lung-Yi
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (05): : 420 - 421
  • [30] Switching from tenofovir disoproxil fumarate to tenofovir alafenamide and hepatic safety: a new paradigm?
    Squillace, N.
    Ricci, E.
    Menzaghi, B.
    Migliorino, G.
    De Socio, G.
    Passerini, S.
    Martinelli, C.
    Mameli, M.
    Maggi, P.
    Falasca, K.
    Cordier, L.
    Celesia, B.
    Salomoni, E.
    Di Biagio, A.
    Pellicano, G.
    Bonfanti, P.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
12345